21139 ⎘
Medicinal preparations containing antigens or antibodies Allergens
DIRECT ANALYSIS OF ANTIGEN-SPECIFIC IMMUNE RESPONSE
#602COMPOSITIONS AND METHODS FOR TREATING AIRWAY INFLAMMATORY DISEASES
#603ZWITTERIONIC IMMUNOMODULATORS FOR THE TEATMENT OF ASTHMA AND ALLERGY
#604USE OF GILZ PROTEIN EXPRESSED IN DENDRITIC CELLS TO MODULATE AN ANTIGEN-SPECIFIC IMMUNE RESPONSE
#605TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#606CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#607Tolerogenic synthetic nanocarriers for allergy therapy
#608Mite allergen
#609TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#610Tolerogenic synthetic nanocarriers
#611Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#612TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#613TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#614Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#615Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#616Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#617Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#618EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS
#619Adenovirus vaccine vector and methods of use
#620Method of treating eosinophilic esophagitis
#621Hypoallergenic hybrid polypeptides for the treatment of allergy
#622ANIMAL MODELS AND THERAPEUTIC MOLECULES
#623ANIMAL MODELS AND THERAPEUTIC MOLECULES
#624Grass peptides for vaccine
#625USE OF AN ADJUVANTED ALLERGY VACCINE FORMULATION FOR PARENTERAL ADMINISTRATION
#626Programming of cells for tolerogenic therapies
#627Allergoids Derived from Allergens
#628Molecular Antigen Array
#629Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of polyclonal IgY antibodies for the detection of intradomiciliary mites
#630Allergen peptide fragments and use thereof for treatment of dust mite allergies
#631SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL
#632SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN
#633Recombinantly produced allergens
#634Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
#635COMBINED ANTIGEN AND DNA VACCINE FOR PREVENTING AND TREATING AUTOIMMUNE DISEASES
#636EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS
#637Geographically Region Specific Allergy Immunotherapy for Companion Animals
#638Dose selection of adjuvanted synthetic nanocarriers
#639Compositions with reduced dimer formation
#640Hypallergenic mosaic antigens and methods of making same
#641Cloning and recombinant productions of venom protease and methods of use thereof
#642Molecule
#643Molecular Antigen Array
#644CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYER'S PATCHES AND USES THEREOF
#645SYNTHETIC NANOCARRIER COMBINATION VACCINES
#646MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
#647NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT
#648STABILIZED PHARMACEUTICAL COMPOSITION, LIQUID PREPARATION OF STABILIZED PHARMACEUTICAL COMPOSITION, FILM-FORM PREPARATION, AND METHOD FOR PRODUCING FILM-FORM PREPARATION
#649Pharmaceutical product for up-dosing of allergy vaccine
#650Treating allergy with detoxified heat-labile enterotoxin
#651Lipid vesicle compositions and methods of use
#652MODIFICATION OF ALLERGENS FOR IMMUNOTHERAPY
#653T cell epitopes of the Cyn d 1 allergen from bermuda grass pollen
#654T-cell antigen peptide from allergen for stimulation of IL-10 production
#655METHODS AND TREATMENT FOR ALLERGIES AND INFLAMMATION ASSOCIATED WITH GASTROINTESTINAL DISEASES
#656MINOR ALLERGEN CONTROL TO INCREASE SAFETY OF IMMUNOTHERAPY
#657Immunotherapy compositions and methods of treatment
#658Pythium immunotherapy
#659MUCOADHESIVE PARTICULATE FORMULATION FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#660Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
#661IMMUNOTHERAPEUTIC METHODS AND SYSTEMS
#662Edible vaccines expressed in soybeans
#663Peptide with reduced dimer formation
#664Long term disease modification using immunostimulatory oligonucleotides
#665DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4
#666Modified beta-lactoglobulins for immunotherapy of milk allergy
#667Method of inducing tolerance to an allergen
#668Angiotensin peptide-carrier conjugates and uses thereof
#669PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE
#670Therapeutical composition containing dentritic cells and use thereof
#671ZWITTERIONIC IMMUNOMODULATORS FOR THE TREATMENT OF ASTHMA AND ALLERGY
#672Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies
#673Allergens from , and method of detecting a mold allergy caused by interior rooms
#674CAT Allergen Conjugates and Uses Thereof
#675RNA Vaccines
#676MICROBIAL DELIVERY SYSTEM
#677IMMUNOGENIC PROTEIN PAS N 1 FROM BAHIA GRASS POLLEN
#678VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
#679Immuniostimulating polyphosphazene compounds
#680DNA sequence, and recombinant preparation of the grass pollen allergen Lol p 4
#681Wheat allergens
#682A COMPOSITION COMPRISING A NOTCH LIGAND AND AN ALLERGENB OR ALLERGEN BYSTANDER ANTIGEN
#683Immunogenic peptides and their use in immune disorders
#684Compositions for treating an intestinal inflammatory condition
#685Peptide with multiple epitopes
#686Allergens and allergoids from bee venom
#687ALLERGY VACCINE COMPOSITION FOR MUCOSAL ADMINISTRATION
#688PHARMACEUTICAL FORMULATION FOR ALLERGEN PREPARATION
#689Allergen desensitization method
#690Peptide for vaccine
#691CARRIER SYSTEM FOR BIOLOGICAL AGENTS CONTAINING ORGANOSILICON COMPOUNDS AND USES THEREOF
#692Adjuvant
#693Vaccine peptide combinations against cat allergy
#694Preparation process and utilization of Poncirus compositions having anti-allergic and antianaphylactic properties
#695Antigen Presenting Cells
#696Oral vaccination
#697Method of inducing immune tolerance to type I diabetes
#698Methods and reagents for decreasing clinical reaction to allergy
#699Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity
#700Compositions and methods for modulating immune responses
#701Methods for reducing allergies caused by environmental allergens
#702Immunotherapeutic method for increasing groundnut tolerance in a subject
#703TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME
#704Prostate kallikrein allergen
#705Compositions Comprising Actinidia and Methods of Use Thereof
#706TREATMENT OF IMMUNE DISEASE BY MUCOSAL DELIVERY OF ANTIGENTS USING GENETICALLY MODIFIED LACTOBACILLUS
#707Molecular Antigen Arrays
#708USE OF A FIRST HOUSE DUST MITE GROUP 2 ALLERGEN FOR TREATING ALLERGY TO A SECOND HOUSE DUST MITE GROUP 2 ALLERGEN
#709MODIFICATION OF ALLERGENS
#710Allergen inactivating agent
#711Cytokine-based fusion proteins for treatment of multiple sclerosis
#712Prevention of allergic sensitization
#713Cloning of honey bee allergen
#714Method for The Production of Hydrolyzed Allergen
#715Vaccine carrier
#716REVERSE TARGETING LIPID VESICLE
#717Use of a Liquid Allergy Vaccine Formulation for Oromucosal Administration
#718Allergenic proteins of natural rubber latex, their production and use in assays
#719Genetic adjuvants for immunotherapy
#720NON-INJECTION IMMUNOTHERAPY
#721USE OF RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOR THE TREATMENT OF TYPE 1 HYPERSENSITIVITY IN A LIVING ANIMAL INCLUDING HUMANS
#722Modified mite allergen and pharmaceutical uses thereof
#723CAT allergen conjugates and uses thereof
#724Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes
#725Allergy Treatment by Epicutaneous Allergen Administration
#726RECOMBINANT LACTOBACILLUS AND USE OF THE SAME
#727VACCINES USING NUCLEIC ACID-LIPID COMPLEXES
#728Process for producing an allergen extract
#729PEPTIDES FOR DIAGNOSTIC AND THERAPEUTIC METHODS FOR CELIAC SPRUE
#730Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein
#731Solid Vaccine Formulation
#732Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#733Induction of mucosal tolerance to antigens
#734IMMUNIZATION-FREE METHODS FOR TREATING ANTIGEN-STIMULATED INFLAMMATION IN A MAMMALIAN HOST AND SHIFTING THE HOST'S ANTIGEN IMMUNE RESPONSIVENESS TO A TH1 PHENOTYPE
#735Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies
#736MUTANT ALLERGEN(S)
#737Vaccine for House Dust Mite Allergen Using Naked DNA
#738House Dust Mite Allergen
#739Apoptotic agents
#740Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response
#741Allergy vaccines and their preparation
#742Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
#743CHEMICALLY-DEFINED NON-POLYMERIC VALENCY PLATFORM MOLECULES AND CONJUGATES THEREOF
#744Molecular antigen arrary
#745Mite allergen
#746Homeopathic composition for alleviating allergy symptoms
#747SHRIMP ALLERGEN, ANTI-SHRIMP ALLERGEN ANTIBODY, AND USE THEREOF
#748Compositions for antigen-specific induction of tolerance
#749Allergen dosage form
#750Allergen dosage form
#751Vaccine composition containing synthetic adjuvant
#752Barn Dust Extract Providing Protection From Allergies
#753Immunointeractive molecules and uses thereof
#754Modified mite allergen and pharmaceutical uses thereof
#755Chemically-defined non-polymeric valency platform molecules and conjugates thereof
#756Therapeutic stem cell composition and stimulant, facilitator, accelerator, and synergizer thereof, growth factor, anti-inflammatory composition and uses thereof
#757Cat dander allergen treatments
#758Therapeutical Composition Containing Dentritic Cells And Use Thereof
#759Edible vaccines expressed in soybeans
#760IMMUNOTHERAPY FOR FOOD ALLERGY BY REDUCED AND ALKYLATED FOOD ALLERGENS
#761Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
#762Allergy inhibitor compositions and kits and methods of using the same
#763Drug therapy for Celiac Sprue
#764DNA sequence, and recombinant preparation of the grass pollen allergen Lol p4
#765Molecular antigen arrays
#766Immunotherapy method
#767Antigen arrays for treatment of bone disease
#768Methods
#769Allergen peptide fragments and use thereof
#770Antigen arrays for treatment of allergic eosinophilic diseases
#771Angiotensin peptide-carrier conjugates and uses thereof
#772Pill dispenser
#773Molecular antigen array
#774Compositions comprising structurally stable conjugate molecules
#775Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
#776Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
#777Allergen-specific immunotherapy
#778Molecule
#779Non-injection immunotherapy
#780Recombinant nucleic acid useful for inducing protective immune response against allergens
#781Packaged virus-like particles
#782Methods of using nucleic acid vector-lipid complexes
#783Cockroach allergen gene expression and delivery systems and uses
#784Minor allergen control to increase safety of immunotherapy
#785Treatment of allergic diseases using a modulator of the Notch signaling pathway
#786Immunostimulating polyphosphazene compounds
#787Peptides for diagnostic and therapeutic methods for celiac sprue
#788Medical treatment
#789Method of preventive treatment of allergy by oromucosal administration of an allergy vaccine
#790Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound
#791Cloning of honey bee allergen
#792Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
#793Conjugated hydroxyalkyl starch allergen compounds
#794Allergy vaccine composition, production method thereof and use of same in allergy treatment
#795Angiotensin peptide-carrier conjugates and uses thereof
#796Fungal antigens and process for producing the same
#797Compositions for inducing of immunotolerance
#798Antigen library immunization
#799Developing oral tolerance for airborne allergens
#800Method of detecting cellular immunity and application thereof to drugs
#801Immunotherapeutic methods and systems
#802Methods of treating IgE-associated disorders and compositions for use therein
#803Local nasal immunotherapy with allergen strip for allergic rhinitis
#804Method of treating allergy and infection by eliciting an IGA antibody response
#805Drug therapy for celiac sprue
#806Oral vaccination
#807Methods and compositions for dosing of allergens
#808Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#809Process for producing dust mite allergen
#810Method for curing mild Multiple Sclerosis, memory impairment and Seasonal Affective Disorder
#811Microparticles comprising carbohydrate beads covalently linked with allergen
#812T cell epitopes of the cyn d 1 allergen from bermuda grass pollen
#813Supression of allergic reactions by transdermal administration of allergens conjugated to cholera toxin or fragments thereof
#814Methods and reagents for decreasing clinical reaction to allergy
#815Variants of mite group 1 allergens for the treatment of house dust mite allergy
#816Processes for inhibiting development of allergic disease
#817Allergenic proteins of natural rubber latex, their production and use in assays
#818Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
#819Compositions for use in treating ige-associated disorders
#820Chemically defined non-polymeric valency platform molecules and conjugates thereof
#821Method of obtaining protection against bystander allergen